JPH0147479B2 - - Google Patents

Info

Publication number
JPH0147479B2
JPH0147479B2 JP55130298A JP13029880A JPH0147479B2 JP H0147479 B2 JPH0147479 B2 JP H0147479B2 JP 55130298 A JP55130298 A JP 55130298A JP 13029880 A JP13029880 A JP 13029880A JP H0147479 B2 JPH0147479 B2 JP H0147479B2
Authority
JP
Japan
Prior art keywords
medium
culture
physiologically active
agar
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55130298A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5754151A (en
Inventor
Eiji Higashide
Satoshi Horii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP55130298A priority Critical patent/JPS5754151A/ja
Priority to US06/300,285 priority patent/US4575489A/en
Priority to DE19813136675 priority patent/DE3136675A1/de
Priority to FR8117581A priority patent/FR2490223B1/fr
Priority to GB8128160A priority patent/GB2084158B/en
Publication of JPS5754151A publication Critical patent/JPS5754151A/ja
Priority to US06/629,499 priority patent/US4623733A/en
Publication of JPH0147479B2 publication Critical patent/JPH0147479B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/887—Streptomyces albus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP55130298A 1980-09-18 1980-09-18 Physiologically active substance b-52653 and its preparation Granted JPS5754151A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP55130298A JPS5754151A (en) 1980-09-18 1980-09-18 Physiologically active substance b-52653 and its preparation
US06/300,285 US4575489A (en) 1980-09-18 1981-09-08 Streptomyces albulus subsp. ochragerus subsp. nov. culture for making peptide
DE19813136675 DE3136675A1 (de) 1980-09-18 1981-09-16 Neues peptid und dessen herstellung
FR8117581A FR2490223B1 (fr) 1980-09-18 1981-09-17 Nouveau peptide, son procede de preparation et culture du microorganisme utilise dans ce procede
GB8128160A GB2084158B (en) 1980-09-18 1981-09-17 Peptide and production thereof
US06/629,499 US4623733A (en) 1980-09-18 1984-07-10 Antimicrobial peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55130298A JPS5754151A (en) 1980-09-18 1980-09-18 Physiologically active substance b-52653 and its preparation

Publications (2)

Publication Number Publication Date
JPS5754151A JPS5754151A (en) 1982-03-31
JPH0147479B2 true JPH0147479B2 (enExample) 1989-10-13

Family

ID=15030963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55130298A Granted JPS5754151A (en) 1980-09-18 1980-09-18 Physiologically active substance b-52653 and its preparation

Country Status (5)

Country Link
US (2) US4575489A (enExample)
JP (1) JPS5754151A (enExample)
DE (1) DE3136675A1 (enExample)
FR (1) FR2490223B1 (enExample)
GB (1) GB2084158B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123155A (en) * 1981-01-26 1982-07-31 Takeda Chem Ind Ltd Preparation of pyrrolidine derivative and its intermediate
ZA832844B (en) * 1982-05-18 1984-03-28 Smithkline Beckman Corp Oligopeptide prodrugs
JPH0672893B2 (ja) * 1985-08-16 1994-09-14 富士薬品工業株式会社 ヒト血中のヒトプロリルヒドロキシラーゼの放射性免疫学的測定法による定量法
US4980283A (en) * 1987-10-01 1990-12-25 Merck & Co., Inc. Renin-inhibitory pepstatin phenyl derivatives
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
GB0206711D0 (en) * 2002-03-21 2002-05-01 Isis Innovation HIF Inhibitor
US20100150985A1 (en) * 2008-04-24 2010-06-17 George Just Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077478A (en) 1960-05-09 1963-02-12 Rohm & Haas 5-hydrocarbon-amino-2-pyrrolidinones and piperidones
US3317559A (en) 1963-08-23 1967-05-02 American Cyanamid Co alpha-amino acid esters of n-hydroxysuccinimide and preparation and use in peptide synthesis
US4355112A (en) * 1977-06-06 1982-10-19 Sanraku-Ocean Co., Ltd. Streptomyces culture
JPS57123155A (en) 1981-01-26 1982-07-31 Takeda Chem Ind Ltd Preparation of pyrrolidine derivative and its intermediate

Also Published As

Publication number Publication date
GB2084158B (en) 1984-05-31
FR2490223B1 (fr) 1985-06-14
JPS5754151A (en) 1982-03-31
US4623733A (en) 1986-11-18
US4575489A (en) 1986-03-11
DE3136675A1 (de) 1982-05-06
GB2084158A (en) 1982-04-07
FR2490223A1 (fr) 1982-03-19

Similar Documents

Publication Publication Date Title
EP0182315A2 (en) Novel antibiotic NK84-0218 pharmaceutical compositions containing it and process for the production of the same
JPH0216756B2 (enExample)
Kuroda et al. FR-900130, a novel amino acid antibiotic I. discovery, taxonomy, isolation, and properties
US4409210A (en) Antibiotic compound
JPH0147479B2 (enExample)
US5648455A (en) Antibiotic WAP-8294A, method for preparing the same and antibacterial composition
US20090023665A1 (en) Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
US4533631A (en) Fermentation process for preparation of antibiotic Bu-2517
JPH01246288A (ja) Ｔａｎ−１０３０ａおよびその誘導体，これらの製造法ならびに用途
JPH01112988A (ja) 新規物質ｄｃ―１０７
JPH0341477B2 (enExample)
JP3530563B2 (ja) Ｋｏ−８１１９物質及びその製造法
JPH0430400B2 (enExample)
JP2640932B2 (ja) Ｔａｎ−８６６、その製造法および微生物
JP2854671B2 (ja) 新規物質ｕｃｆ１
JP2766351B2 (ja) 新規物質ｄｃ１１４―ｃ
JP2786219B2 (ja) Ｙ―０９１９４ｌ―ｂ物質および該物質の製造法
JP2002226499A (ja) 抗生物質ｇｅ２３０７７、その医薬上許容される塩および組成物ならびにそれらの用途
JPS63152992A (ja) 抗生物質ｔａｎ−８７６およびその製造法
JPH04633B2 (enExample)
JPH021139B2 (enExample)
JPH02142799A (ja) 新規なグリコペプチド抗生物質のデカプラニン
JPH0565297A (ja) エノペプチンａ、その製造方法、並びに抗ウイルス剤
JPS6125356B2 (enExample)
JP2000197499A (ja) 新規化合物及びその製造法